<DOC>
	<DOCNO>NCT01287507</DOCNO>
	<brief_summary>The aim study evaluate whether oral administration 200 mg/day lactoferrin ( LF ) low birth weight infant reduce late onset sepsis necrotising enterocolitis effect LF regulatory T cell .</brief_summary>
	<brief_title>Lactoferrin Prophylaxis VLBW Regulator T-cells</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Birth Weight</mesh_term>
	<mesh_term>Enterocolitis</mesh_term>
	<mesh_term>Enterocolitis , Necrotizing</mesh_term>
	<mesh_term>Lactoferrin</mesh_term>
	<criteria>Inborn infant Gestational age &lt; 32 week Birth weight &lt; 1500 g Parental consent Congenital abnormality Severe perinatal asphyxia</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Day</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>VLBW , NEC , Late onset sepsis</keyword>
</DOC>